Literature DB >> 26429404

Dead Space Management After Orthopaedic Trauma: Tips, Tricks, and Pitfalls.

Mark J Gage1, Richard S Yoon, Robert J Gaines, Robert P Dunbar, Kenneth A Egol, Frank A Liporace.   

Abstract

UNLABELLED: Dead space is defined as the residual tissue void after tissue loss. This may occur due to tissue necrosis after high-energy trauma, infection, or surgical debridement of nonviable tissue. This review provides an update on the state of the art and recent advances in the management of osseous and soft tissue defects. Specifically, our focus will be on the initial dead space assessment, provisional management of osseous and soft tissue defects, techniques for definitive reconstruction, and dead space management in the setting of infection. LEVEL OF EVIDENCE: Therapeutic Level V. See Instructions for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2016        PMID: 26429404     DOI: 10.1097/BOT.0000000000000454

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  4 in total

1.  Novel method to create a bespoke cement spacer for use in the management of segmental long-bone defects.

Authors:  Z Silk; A Vris
Journal:  Ann R Coll Surg Engl       Date:  2019-06-03       Impact factor: 1.891

Review 2.  [Primary soft tissue management in open fracture].

Authors:  F Riechelmann; P Kaiser; R Arora
Journal:  Oper Orthop Traumatol       Date:  2018-09-04       Impact factor: 1.154

3.  High Cefuroxime Concentrations and Long Elimination in an Orthopaedic Surgical Deadspace-A Microdialysis Porcine Study.

Authors:  Sara Kousgaard Tøstesen; Maiken Stilling; Pelle Hanberg; Theis Muncholm Thillemann; Thomas Falstie-Jensen; Mikkel Tøttrup; Martin Knudsen; Emil Toft Petersen; Mats Bue
Journal:  Antibiotics (Basel)       Date:  2022-02-07

4.  Comparative osteoconductivity of bone void fillers with antibiotics in a critical size bone defect model.

Authors:  Rema A Oliver; Vedran Lovric; Chris Christou; William R Walsh
Journal:  J Mater Sci Mater Med       Date:  2020-08-25       Impact factor: 3.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.